Skip to main content
HRES 611 111th Congress House Health Commemorative events and holidays Congressional tributes Disability and paralysis Genetics Health care costs and insurance Health care coverage and access Health information and medical records Health programs administration and funding Hereditary and development disorders Medical research Medical tests and diagnostic methods Research administration and funding

Supporting the goals and ideals of "Fragile X Awareness Day".

Introduced: July 7, 2009 See on congress.gov
 Everywhere this bill has been 9 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Jul 21, 2010
Motion to reconsider laid on the table Agreed to without objection.
Jul 21, 2010
On motion to suspend the rules and agree to the resolution, as amended Agreed to by voice vote. (text: CR H5880)
Jul 21, 2010
Passed/agreed to in House: On motion to suspend the rules and agree to the resolution, as amended Agreed to by voice vote.(text: CR H5880)
Jul 21, 2010
DEBATE - The House proceeded with forty minutes of debate on H. Res. 611.
Jul 21, 2010
Considered under suspension of the rules. (consideration: CR H5880-5882)
Jul 21, 2010
Mr. Pallone moved to suspend the rules and agree to the resolution, as amended.
Jul 8, 2009
Referred to the Subcommittee on Health.
Jul 7, 2009
Referred to the House Committee on Energy and Commerce.
Jul 7, 2009
Introduced in House
 Plain-English summary Congressional Research Service

Expresses support for: (1) the goals and ideals of Fragile X Awareness Day; (2) raising awareness and educating the public about fragile X syndrome and associated disorders; and (3) funding for research into the causes, treatment, and cure for fragile X syndrome.

Applauds efforts to encourage awareness, promote research, and provide education, support, and hope to those impacted by fragile X syndrome. Recognizes the commitment of those dedicated to finding an effective treatment and cure.

Urges physicians, health care providers, and specialists, with respect to the syndrome and related disorders, to: (1) learn the clinical signs and symptoms; (2) use diagnostic, developmental screening, and surveillance modalities for detection; (3) test individuals exhibiting signs of developmental delay or an autism spectrum disorder to determine the status of their FMR1 gene; (4) gain a full understanding of the genetic implications and make appropriate referrals to a geneticist or genetic counselor; and (5) provide diagnosed patients with supplemental information.

Recommends that the National Institutes of Health (NIH) and related member institutes implement the research plan on fragile X syndrome and associated disorders developed by the Trans-NIH Fragile X Research Coordinating Group and Scientific Working Groups.

What's happening now July 21, 2010

Motion to reconsider laid on the table Agreed to without objection.

 Committees of jurisdiction 2